INDP Indaptus Therapeutics Inc
Company Analysis
Latest News
🟢 Indaptus Therapeutics is trading 5% up in after-hours trading with no clear catalyst identified
Indaptus Therapeutics is trading 5.29% higher at $3.48 in after-hours trading, with no clear company-specific announcement identified to explain the move. -...
🟢 Indaptus Therapeutics is trading 5% up
Indaptus Therapeutics is trading 5.18% higher at $3.32 on October 26, 2026, with no specific catalyst identified. - The recently reported $24 million private...
🟢 Indaptus Therapeutics is trading 5.7% up
Indaptus Therapeutics is trading 5.69% higher at $3.16 on October 23, 2026, with no identified company-specific catalyst for the intraday gain. - Recent...
🔴 Indaptus Therapeutics is trading 6.8% down today amid risk-off pressure on growth stocks
Indaptus Therapeutics is trading at $2.94, down 6.80%, amid broader risk-off pressure on growth stocks. - No new company-specific catalyst explaining the...
🟢 Indaptus Therapeutics is trading 5% up in pre-market — no company-specific catalyst identified
Indaptus Therapeutics is trading at $3.32, up 5.06% in pre-market, with no identified company-specific announcement explaining the move. - No new...
🟢 Indaptus Therapeutics is trading 6% up today amid broader biotech gains
Indaptus Therapeutics is trading at $3.14, up 6.08%, amid broader biotech strength. - No company-specific announcement explaining the October 21 move was...
Indaptus Therapeutics Completes $24 Million Private Placement
Indaptus Therapeutics, Inc. announced the successful closing of its previously disclosed private placement, raising approximately $24.0 million in gross...
🟢 Indaptus Therapeutics is trading 5% up today amid biotech-sector strength
Indaptus Therapeutics is trading at $2.87, up +5.09%, with biotech-sector strength a possible backdrop to the October 20 move. - The supplied sector data shows...
🟢 Indaptus Therapeutics is trading 5.7% up on October 19, 2026, amid broader biotech-sector gains
Indaptus Therapeutics is trading at $2.78, up 5.70% during the October 19 session, with the gain most consistent with supportive biotech-sector sentiment—not a...
🔴 Indaptus Therapeutics is trading 5% down; no clear catalyst identified
Indaptus Therapeutics is trading 5.26% down at $2.70, with no clear catalyst identified for the October 16 move. - No fresh company announcement surfaced; the...
🟢 Indaptus Therapeutics is trading 14.7% up with no clear catalyst
Indaptus Therapeutics is trading 14.71% higher at $2.54, with the reason for the October 15 move unclear. - No fresh company announcement explaining the move...
🟢 Indaptus Therapeutics is trading 6.3% up
Indaptus Therapeutics is trading at $2.40, up +6.33%, with no verified catalyst identified for the rise. - No fresh company announcement explaining the October...
🔴 Indaptus Therapeutics is trading 10% down on October 14, 2026 amid hotter CPI and biotech weakness
Indaptus Therapeutics is trading at $2.15 (-10.04%) amid broader market pressure following hotter-than-expected headline CPI and weakness in biotech stocks. -...
🔴 Indaptus Therapeutics is trading 6.7% down
Indaptus Therapeutics is trading 6.7% down at $2.23, and the reason for the decline remains unclear. - No company announcement dated October 14 was identified;...
🟢 Indaptus Therapeutics is trading 7.3% up in pre-market
Indaptus Therapeutics is trading at $2.56, up 7.29% in pre-market; available evidence does not establish a specific cause. - The previous session closed at...
🟢 Indaptus Therapeutics is trading 5% up
Indaptus Therapeutics is trading 5.18% higher at $2.64 on October 12, 2026; no fresh company-specific announcement has been identified to explain the move. -...
🟢 Indaptus Therapeutics is trading 6.1% up
Indaptus Therapeutics is trading 6.1% higher at $2.52 on October 9, 2026, with no fresh company-specific announcement identified to explain the move. -...
🟢 Indaptus Therapeutics is trading 5.3% up
Indaptus Therapeutics is trading 5.31% higher at $2.38, with no clear catalyst identified for the October 8 move. - The available news check found no fresh...
🟢 Indaptus Therapeutics is trading 9.3% up in pre-market
Indaptus Therapeutics is trading at $2.47, up 9.29% in pre-market, with no fresh company-specific announcement identified to explain the rise. - Available...
🟢 Indaptus Therapeutics is trading 10.62% up in after-hours trading
Indaptus Therapeutics is trading 10.62% higher at $2.50 in after-hours trading, with no fresh company-specific announcement identified to explain the gain. -...